An adapted health system inequity framework for avoidable inflammatory bowel disease admissions: A scoping review

preprint OA: closed
📄 Open PDF Full text JSON View at publisher

Abstract

Background Access to healthcare may be driving unplanned and potentially avoidable hospital admissions for people diagnosed with Inflammatory Bowel Disease (IBD). Interventions to reduce unplanned and potentially avoidable admissions need to be developed based on a clear conceptual framework that identifies the system-level access barriers contributing to these admissions. This scoping review aimed to synthesise the health system components for reducing unplanned IBD admissions to develop a conceptual framework to guide future interventions for reducing unplanned admissions. Methods A scoping review was conducted to identify literature exploring factors associated with unplanned IBD admissions and interventions to reduce IBD admissions. Literature published between January 2000 and October 2024 was identified from four electronic databases (Medline, Embase, CINAHL and Pubmed). A narrative synthesis presented the findings, guided by Candidacy Framework, to understand issues in healthcare access. Results and conclusions Of 1980 records identified, 17 were included. Avoidable IBD admissions result from inequity across the patient journey through healthcare specifically in access to: (1) earlier intervention during a flare, (2) specialist clinical advice about symptoms and psychosocial issues, (3) rapid access to outpatient care, (4) patient education, (5) systems that support self-management, (6) proactive care strategies, and (7) collaborative health professional working and referrals. Addressing service permeability (ease of using services) and local production of candidacy (patient-provider relationships and macro-structural conditions) are understood as most important for addressing avoidable unplanned IBD admissions. The Health System Access Framework is useful for understanding how services need to address patient care. Lay summary Many unplanned hospital admissions for inflammatory bowel disease may be avoided. This review found that quicker access to specialist advice, proactive care, and patient education is crucial. This study developed a framework to help healthcare providers improve services and reduce these admissions for patients.
Full text 4,243 characters · extracted from oa-doi-fallback · 3 sections · click to expand

Abstract

Background Access to healthcare may be driving unplanned and potentially avoidable hospital admissions for people diagnosed with Inflammatory Bowel Disease (IBD). Interventions to reduce unplanned and potentially avoidable admissions need to be developed based on a clear conceptual framework that identifies the system-level access barriers contributing to these admissions. This scoping review aimed to synthesise the health system components for reducing unplanned IBD admissions to develop a conceptual framework to guide future interventions for reducing unplanned admissions.

Methods

A scoping review was conducted to identify literature exploring factors associated with unplanned IBD admissions and interventions to reduce IBD admissions. Literature published between January 2000 and October 2024 was identified from four electronic databases (Medline, Embase, CINAHL and Pubmed). A narrative synthesis presented the findings, guided by Candidacy Framework, to understand issues in healthcare access.

Results

and conclusions Of 1980 records identified, 17 were included. Avoidable IBD admissions result from inequity across the patient journey through healthcare specifically in access to: (1) earlier intervention during a flare, (2) specialist clinical advice about symptoms and psychosocial issues, (3) rapid access to outpatient care, (4) patient education, (5) systems that support self-management, (6) proactive care strategies, and (7) collaborative health professional working and referrals. Addressing service permeability (ease of using services) and local production of candidacy (patient-provider relationships and macro-structural conditions) are understood as most important for addressing avoidable unplanned IBD admissions. The Health System Access Framework is useful for understanding how services need to address patient care. Lay summary Many unplanned hospital admissions for inflammatory bowel disease may be avoided. This review found that quicker access to specialist advice, proactive care, and patient education is crucial. This study developed a framework to help healthcare providers improve services and reduce these admissions for patients. Competing Interest Statement AJL has acted as a speaker or consultant for Takeda, BMS, Sandoz, JNJ, Celltrion and Medtronic. Funding Statement Funding from The University of Sheffield PhD Research Scholarships is acknowledged in supporting RLH to conduct this review. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Footnotes Financial disclosures: Funding from The University of Sheffield PhD Research Scholarships is acknowledged in supporting RLH to conduct this review. Conflicts of interest: AJL has acted as a speaker or consultant for Takeda, BMS, Sandoz, JNJ, Celltrion and Medtronic. Data availability: Data available in supplementary material Term "inequity" has been updated to "access" in title of the framework. Further clarification on difference between this scoping rev iew and a health inequalities review we conducted in IBD care added. Data Availability All data produced in the present work are contained in the manuscript

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00